🔎 Trials Near Me

Nyumbani › Magonjwa ya Autoimmune › Kansas

Majaribio ya kliniki ya Magonjwa ya Autoimmune katika jimbo la Kansas

Masomo 7 ya Magonjwa ya Autoimmune yanatafuta washiriki katika vituo vya jimbo la Kansas.

Miji katika jimbo la Kansas

Maandishi rasmi ya utafiti (Kiingereza)

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

  • University of Kansas Clinical Research Center, Fairway
  • HaysMed, Hays
  • University of Kansas Cancer Center, Kansas City
  • na zaidi ya 7
InaajiriHatua 1
Umri 18 na zaidi · Jinsia zote · Imesasishwa 23 Sep 2026 · NCT03816345

RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy

  • University of Kansas Medical Center - Accepting Adult Patients, Kansas City
InaajiriHatua 2/3
Umri 6 hadi 75 · Jinsia zote · Imesasishwa 17 Sep 2026 · NCT06154252

A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease

  • University of Kansas Medical Center, Kansas City
InaajiriHatua 1
Umri 18 hadi 74 · Jinsia zote · Imesasishwa 10 Sep 2026 · NCT07085104

RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus

  • University of Kansas Medical Center, Kansas City
InaajiriHatua 1/2
Umri 18 hadi 65 · Jinsia zote · Imesasishwa 26 Ago 2026 · NCT06121297

RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis

  • University of Kansas Medical Center, Kansas City
InaajiriHatua 2/3
Umri 18 hadi 75 · Jinsia zote · Imesasishwa 17 Ago 2026 · NCT06328777

RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis

  • University of Kansas Medical Center, Kansas City
InaajiriHatua 1/2
Umri 18 hadi 70 · Jinsia zote · Imesasishwa 13 Ago 2026 · NCT06359041

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

  • University of Kansas, Westwood
InaajiriUtafiti wa uchunguzi
Umri wote · Jinsia zote · Imesasishwa 6 Jul 2026 · NCT01351545

Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.